Manina Medtech
Manina Medtech is developing Seedchrony, a non-invasive, immediate, and accurate system to assess uterine readiness for embryo transfer, aiming to increase pregnancy rates by 30% in IVF treatments. Seedchrony analyzes biomarker data within the uterus and provides AI-based recommendations to doctors, enabling more informed and individualized embryo transfers by preserving endometrial integrity without biopsies. The company's solution addresses the critical need for improved precision in evaluating endometrial development to synchronize the embryo and endometrium, a key factor for reproductive success in assisted reproduction treatments.
Manina Medtech
Manina Medtech is developing Seedchrony, a non-invasive, immediate, and accurate system to assess uterine readiness for embryo transfer, aiming to increase pregnancy rates by 30% in IVF treatments. Seedchrony analyzes biomarker data within the uterus and provides AI-based recommendations to doctors, enabling more informed and individualized embryo transfers by preserving endometrial integrity without biopsies. The company's solution addresses the critical need for improved precision in evaluating endometrial development to synchronize the embryo and endometrium, a key factor for reproductive success in assisted reproduction treatments.